Precision For Medicine Partners With Karyopharm Therapeutics To Initiate New Global Clinical Trial To Treat Patients With COVID-19
-- First Study of an XPO1 Inhibitor to Treat Patients with Severe Viral Infections -- Precision for Medicine Responsible for Clinical Trial Management in Europe BUDAPEST, Hungary, April 22, 2020 /PR...